Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Human Molecular Genetics|October 26, 2005
Pharmacogenetics/genomics and personalized medicineWolfgang Sadée, Zunyan Dai
Current Topics in Medicinal Chemistry|September 24, 2004
Growth factor signaling and resistance to cancer chemotherapyZunyan Dai, Ying Huang, Wolfgang Sadée
American Journal of Medical Genetics. Part A|April 10, 2014
Haploinsufficiency of HDAC4 does not cause intellectual disability in all affected individualsPatricia G Wheeler, Dongli Huang, Zunyan Dai
Cancer Research|August 17, 2005
Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistanceYing Huang, Zunyan Dai, Catalin Barbacioru, et al.
Biochemical and Biophysical Research Communications|October 27, 2006
5-Aza-2'-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer)Zunyan Dai, Shujun Liu, Guido Marcucci, et al.
Pharmaceutical Research|January 21, 2006
Prediction of anticancer drug potency from expression of genes involved in growth factor signalingZunyan Dai, Catalin Barbacioru, Ying Huang, et al.
Molecular Pharmaceutics|October 3, 2006
A pharmacoproteomics study of the cancer cell line EKVX using capillary-LC/MS/MSYonghui Wang, Zunyan Dai, Wolfgang Sadee, et al.
BMC Medical Genomics|June 13, 2008
Genotyping panel for assessing response to cancer chemotherapyZunyan Dai, Audrey C Papp, Danxin Wang, et al.
European Journal of Human Genetics : EJHG|May 26, 2011
A common spinal muscular atrophy deletion mutation is present on a single founder haplotype in the US HutteritesJessica X Chong, A Afşin Oktay, Zunyan Dai, et al.
Pageof 4